Bio-Rad Laboratories Class B
BIO.B
8 hedge funds and large institutions have $1.08M invested in Bio-Rad Laboratories Class B in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 6 → 8 (+2)
0% less ownership
Funds ownership: 0.07% → 0.07% (-0%)
3% less capital invested
Capital invested by funds: $1.11M → $1.08M (-$29.3K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IUHSA
Itau Unibanco Holding S.A.
Sao Paulo,
Brazil
|
+$42.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$332 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CSS LLC
Chicago,
Illinois
|
-$50.1K |
BIO.B Hedge Fund Activity: Q4 2024 in Review
8 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q4 2024, worth a combined $1.08M — down 2.6% from $1.11M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BIO.B positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Itau Unibanco Holding S.A., opening a new position worth an estimated $42.1K. The largest seller was CSS LLC, cutting an estimated $50.1K.
- 8 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q4 2024, up from 6 in Q3 2024.
- Funds reported $1.08M of Bio-Rad Laboratories Class B stock for Q4 2024, down 2.6% quarter-over-quarter.
- 2 funds opened new Bio-Rad Laboratories Class B positions in Q4 2024 and 0 closed out, a net change of +2 holders.
- The largest Bio-Rad Laboratories Class B buyer in Q4 2024 was Itau Unibanco Holding S.A., an estimated $42.1K added.
- The largest Bio-Rad Laboratories Class B seller in Q4 2024 was CSS LLC, an estimated $50.1K sold.
Based on aggregated 13F filings for Q4 2024.